2010 pharma results
Bayer goes for pharma growth
March 1, 2011Research and Development, Sales and Marketing 2010 pharma results, Bayer, Dr Jörg Reinhardt, Marijn Dekkers, Nexavar, VEGF Trap-Eye, Xarelto
While many of its larger peers in the pharma sector are rushing to diversify into consumer health and generics, Bayer, …
Merck KGaA sales soar
February 21, 2011Sales and Marketing 2010 pharma results, Cladribine, Merck KGaA, Merck Serono, Movectro
Merck KGaA’s sales jumped last year by nearly a fifth as recent acquisitions and strong growth on core products set …
Shire thrives on specialist portfolio
February 11, 2011Sales and Marketing 2010 pharma results, ADHD, Shire, Vyvanse
Speciality pharma company Shire has posted sales growth of 16%, led by its ADHD treatment Vyvanse. Sales of Vyvanse rose …
Generics force Sanofi into standstill
February 9, 2011Sales and Marketing 2010 pharma results, Jevtana, Multaq, Sanofi, Sanofi-Aventis, generics
An onslaught of generic competition combined with healthcare cuts in the US and Europe meant Sanofi-Aventis’ revenues were brought to …
Teva surges ahead
February 9, 2011Sales and Marketing 2010 pharma results, Copaxone, Teva, Teva Pharmaceutical
Generics giant Teva enjoyed a strong year of growth in 2010, lifted by the acquisition of Ratiopharm, patent expiries of …
GSK profits slump amid ongoing Avandia woes
February 7, 2011Sales and Marketing 2010 pharma results, Avandia, GSK, GlaxoSmithKline
GlaxoSmithKline’s ongoing woes with diabetes drug Avandia hit profits in 2010. Profits after tax plummeted 56% to £3 billion for …
Merck dipped into the red as 2010 ended
February 4, 2011Sales and Marketing 2010 pharma results, Merck & Co
Merck & Co made a $531 million loss in the final quarter of 2010 – down from a profit of …
Roche weathers tough year and looks to pipeline for 2011
February 3, 2011Research and Development, Sales and Marketing 2010 pharma results, BRAF protein, GDC-0449, RG3616, RG7204, Roche, avastin, pertuzumab
Roche is looking to its innovative late-stage pipeline to help it get back on track for the next financial year …
Novartis posts strong growth but warns of tough year ahead
January 27, 2011Sales and Marketing 2010 pharma results, Novartis
Novartis has posted strong sales growth for the full year but its chief executive warns of ‘headwinds in 2011’ as …
J&J posts negative growth as pharma sales stall
January 26, 2011Sales and Marketing 2010 pharma results, J&J, JJ, Johnson and Johnson, Remicade, Risperdal Consta
Falling fourth quarter sales of Risperdal Consta and Remicade capped a year to forget for Johnson and Johnson. The company’s …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
